1 / 12

Framework to structure the discussion on the role of the EMCDDA in the monitoring of drug supply in Europe

Framework to structure the discussion on the role of the EMCDDA in the monitoring of drug supply in Europe. Prof dr. Brice De Ruyver Meeting Scientific Committee EMCDDA November 2008. Key Questions. How can the EMCDDA develop drug supply information, collection and analysis?

cachet
Download Presentation

Framework to structure the discussion on the role of the EMCDDA in the monitoring of drug supply in Europe

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Framework to structure the discussion on the role of the EMCDDA in the monitoring of drug supply in Europe Prof dr. Brice De Ruyver Meeting Scientific Committee EMCDDA November 2008

  2. Key Questions • How can the EMCDDA develop drug supply information, collection and analysis? • What data should the EMCDDA collect in the area of supply in order to fulfil its mandate? • Who could be national partners? • What could be topics? • How to link demand reduction and supply reduction information?

  3. Starting points 1. The EMCDDA plays a role to map the supply-side. • Not the core-business of the EMCDDA, but the task of other organisations. • UNODC, Interpol, Europol: specific areas/ drug production and trafficking linked to organised crime  large-scale and geographically limited.

  4. Starting points 2. European drug policy stands for an integrated policy, starting from an epidemiological basis, influencing the demand- and supply-side. Attaining this by: • A spectrum of facilities in the fields of prevention, treatment, harm reduction and aftercare= tackling the demand-side. • Roughly: law enforcement (criminal, administrative and fiscal law measures)= tackling the supply-side.

  5. Starting points 3. Phenomenological: demand- andsupply-sideinteractconstantly. • Thisinteraction is very evolutiveforspecificareas of the drug market (synthetic drugs, retailtrade) alsoconcerning the supply, priceandquality. • Push on the supply-sidecreatesdemand-side (push-factor) The phase in whichdemandandsupply meet on the illegal drug market = very relevant • For the actorsanddomainswhichinfluence the demand-side. • For the actorswho tackle the supply-side.

  6. Starting points • Itcompletes the sightupon the integralsupply-chain essentialtocombat the supply-side in itsentirety. • Yields a lot of informationabout: • How the supply-sideinfluences the demand-side. • The usedmarketstrategies. • The way the demand-side looks forentranceto the supply-channelsand the issues derivingfrom the latter (drug tourism, drug related crime and drug relatednuisance).

  7. Starting points 4. Gaininsightinto the nature of the drug market contextualisingessential. Thiscontextualisationrelatesto: • Political factors (national, (EU)-regional, local). • Cultural factors (traditions in a multicultural society, the Dutch coffee shops). • Economic factors (illegaleconomy as a push-factor).

  8. Conclusion 1. UN-annual reports (UNODC, CND, INCB) • Based upon questionnaires of member states and feeded by law enforcement-dates derived from seizures (= 10% of the real scale). 2. Interpol • Is ± reliable concerning the seizures, but some limitations can be stressed (only registered seizures  activity measure of the police and customs + cfr. supra). • As worldwide structured organisation, Europol offers a quite fragmental picture.

  9. Conclusion 3. Europol • Not able to play a prominent role in supply data registering. • Fails to produce strategical analysis of the drug traffic from the EU, which should be the case (entrance to Interpol-data, h.o.-network). • OCTA (monitoring-based) only gives a fragmental picture. • Not the appropriate instrument to concern itself with regional and local drug markets. 4. Customs • WCO: worldwide, well-structured  very thorough perception of drug traffics.

  10. Conclusion • Conclusion: There is a big gap in the monitoring of regional and local drug markets.

  11. Proposal 1. Need for strategical consultation between all international services which collect information about the supply-side. • Aim: to complete the monitoring on the integral supply-chain particulary with qualitative data (due to the impossibility to deliver complete and reliable quantitative data).

  12. Proposal 2. For the reasons mentioned before, the EMCDDA can play an important role with regard to the qualitative aspects of the micro-supply- monitoring (regional and local drug markets). The macro-supply is more a task for more law enforcement –oriented organisations. 3. How? The EMCDDA can depend on the appropriate channels (NFP’s, expert meetings, selected issues) for the delivery of data, its contextualisation (cfr supra) and the instigation of strategic policy analysis.

More Related